Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10923
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Apa, Ferda | - |
dc.contributor.author | Ate?ci, F.Ç. | - |
dc.contributor.author | Varma, G.S. | - |
dc.date.accessioned | 2019-08-16T13:33:55Z | |
dc.date.available | 2019-08-16T13:33:55Z | |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1302-0099 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10923 | - |
dc.identifier.uri | https://doi.org/10.5505/kpd.2018.19970 | - |
dc.description.abstract | Valproic acid (VPA) is commonly used drug to treat variety of anticonvulsant and mood stabilizer in psychiatric and neurologic cases. It is thought to be a safe drug with a large therapeutic aspect..Uncommonly, hyperammonemia can be progressed by the usage of valproate and VPA induced hyperammonemia delirium-like condition by extrahepatic origin can be constituted. Being unrecognized of this situation in a timely manner can result in encephalopathy and even death. The measurement of the level of ammonia is important to establish a potentially lethal but reversible situation. In this case study, it is aimed that to present hyperammonemia related to the use of psychotropic drugs and to present a patient with hyperammonemia during VPA and antipsychotic use without a medical disease except bipolar disorder in the past. © 2018 ANP Publishing. All rights reserved. | en_US |
dc.language.iso | tr | en_US |
dc.publisher | ANP Publishing | en_US |
dc.relation.ispartof | Klinik Psikiyatri Dergisi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hyperammonemia | en_US |
dc.subject | Non-hepatic encephalopathy | en_US |
dc.subject | Valproic acid | en_US |
dc.title | Valproic acid induced hyperammonemic encephalopathy: A case report | en_US |
dc.type | Editorial | en_US |
dc.identifier.volume | 21 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 102 | |
dc.identifier.startpage | 102 | en_US |
dc.identifier.endpage | 106 | en_US |
dc.identifier.doi | 10.5505/kpd.2018.19970 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.scopus | 2-s2.0-85045298682 | en_US |
dc.identifier.wos | WOS:000432255900012 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.languageiso639-1 | tr | - |
item.openairetype | Editorial | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
Valproik Asit.pdf | 72.21 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
1
checked on Mar 29, 2025
WEB OF SCIENCETM
Citations
1
checked on Apr 1, 2025
Page view(s)
88
checked on Mar 4, 2025
Download(s)
236
checked on Mar 4, 2025
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.